Advertisement

Neurotoxicity Research

, Volume 33, Issue 2, pp 353–361 | Cite as

The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference

  • Ju-ping Li
  • Peng Liu
  • Gang Lei
  • Zheng Chu
  • Fei Liu
  • Chao-feng Shi
  • Yong-hui DangEmail author
  • Teng ChenEmail author
ORIGINAL ARTICLE

Abstract

Drug addiction is a chronically relapsing disorder in humans; yet, the underlying mechanism remained unclear. Recent studies suggested that the histidine triad nucleotide binding protein 1 (HINT1) may play significant roles in diverse neuropsychiatric diseases including drug addiction. In our present study, we used different batches of mice to establish the different stages of methamphetamine (METH)-induced conditioned place preference (CPP) to explore the dynamic changes throughout the process of addiction in different brain regions, including prefrontal cortex (PFC), nucleus accumbens (NAc), corpus striatum (CPu), and hippocampus (Hip). We found that in NAc of the METH group mice, the HINT1 expression level initially increased after acquisition phases, and then dropped to the normal level after extinction phase, and again increased after reinstatement phase. However, there was no statistical difference in the HINT1 expression level in other three encephalic regions (PFC, CPu, and Hip). Therefore, the HINT1 protein, particularly in the NAc, plays a vital role in the METH-induced CPP. However, the precise mechanisms will require further investigation.

Keywords

HINT1 Methamphetamine Conditioned place preference 

Notes

Acknowledgements

This research was supported by the National Science Foundation of China (NSFC81171262, 81771435, 81371473 to Yong-hui Dang), and the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM8078 to Yong-hui Dang).

Compliance with Ethical Standards

The experimental protocol was approved by the Institutional Animal Care Committee of Xi’an Jiaotong University.

Conflict of Interest

The authors declare that they have no conflicts of interest.

References

  1. Allen RM, Everett CV, Nelson AM, Gulley JM, Zahniser NR (2007) Low and high locomotor responsiveness to cocaine predicts intravenous cocaine conditioned place preference in male Sprague-Dawley rats. Pharmacol Biochem Behav 86:37–44CrossRefPubMedGoogle Scholar
  2. Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A, Shippenberg T, Wang JB (2007) Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology 32:1774–1782CrossRefPubMedGoogle Scholar
  3. Baron M (2001) Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet 68:299–312CrossRefPubMedPubMedCentralGoogle Scholar
  4. Cunningham CL, Gremel CM, Groblewski PA (2006) Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1:1662–1670CrossRefPubMedGoogle Scholar
  5. Dang YH, Liu ZW, Chen F, Guo K, Wang JB (2014) Histidine triad nucleotide-binding protein 1 and human diseases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 36:454–460PubMedGoogle Scholar
  6. Fang J, Wang X, He B (2014) Association between common genetic variants in the opioid pathway and smoking behaviors in Chinese men. Behav Brain Funct 10:2CrossRefPubMedPubMedCentralGoogle Scholar
  7. Garzon J, Rodriguez-Munoz M, Sanchez-Blazquez P (2012) Direct association of mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. Curr Drug Abuse Rev 5:199–226CrossRefPubMedGoogle Scholar
  8. Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN (2008) Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull 134:301–310CrossRefPubMedGoogle Scholar
  9. Hyman SE (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162:1414–1422CrossRefPubMedGoogle Scholar
  10. Jackson KJ, Chen Q, Chen J, Aggen SH, Kendler KS, Chen X (2011) Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. Pharmacogenomics J 11:251–257CrossRefPubMedGoogle Scholar
  11. Jackson KJ, Wang JB, Barbier E, Damaj MI, Chen X (2013) The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice. Neurosci Lett 550:129–133CrossRefPubMedGoogle Scholar
  12. Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, Markx S, Lieberman JA, Javitch JA (2010) Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol Sci 31:381–390CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kauer JA (2004) Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66:447–475CrossRefPubMedGoogle Scholar
  14. Kelley AE, Berridge KC (2002) The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22:3306–3311PubMedGoogle Scholar
  15. Kelley AE, Andrzejewski ME, Baldwin AE, Hernandez PJ, Pratt WE (2003) Glutamate-mediated plasticity in corticostriatal networks: role in adaptive motor learning. Ann N Y Acad Sci 1003:159–168CrossRefPubMedGoogle Scholar
  16. Klein DA, Gulley JM (2009) Reduced sensitivity to the locomotor-stimulant effects of cocaine is associated with increased sensitivity to its discriminative stimulus properties. Behav Pharmacol 20:67–77CrossRefPubMedGoogle Scholar
  17. Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y, Weinstein IB (1998) Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family. Exp Cell Res 244:26–32CrossRefPubMedGoogle Scholar
  18. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238CrossRefPubMedGoogle Scholar
  19. Li H, Zhang Y, Su T, Santella RM, Weinstein IB (2006) Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25:713–721CrossRefPubMedGoogle Scholar
  20. Liu Q, Puche AC, Wang JB (2008) Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem Res 33:1263–1276CrossRefPubMedGoogle Scholar
  21. Mandt BH, Schenk S, Zahniser NR, Allen RM (2008) Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine. Psychopharmacology 201:195–202CrossRefPubMedPubMedCentralGoogle Scholar
  22. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449CrossRefPubMedGoogle Scholar
  23. NIDA(1969). Methamphetamine. Vol., ed.^eds. NIDA(1969)Google Scholar
  24. Paxinos G, Franklin KB (2004) The mouse brain in stereotaxic coordinates. Gulf Professional Publishing, Vol.Google Scholar
  25. Robertson SD, Matthies HJ, Galli A (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39:73–80CrossRefPubMedPubMedCentralGoogle Scholar
  26. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53CrossRefPubMedGoogle Scholar
  27. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623–637CrossRefPubMedPubMedCentralGoogle Scholar
  28. Rodriguez-Munoz M, de la Torre-Madrid E, Sanchez-Blazquez P, Wang JB, Garzon J (2008) NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of mu-opioid receptors. Cell Signal 20:1855–1864CrossRefPubMedGoogle Scholar
  29. Rodriguez-Munoz M, Sanchez-Blazquez P, Vicente-Sanchez A, Bailon C, Martin-Aznar B, Garzon J (2011) The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol Life Sci 68:2933–2949CrossRefPubMedGoogle Scholar
  30. Rodriguez-Munoz, M, Sanchez-Blazquez, P, Merlos, M, Garzon-Nino, J (2016) Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget Google Scholar
  31. Romanova EV, Lee JE, Kelleher NL, Sweedler JV, Gulley JM (2010) Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine. AAPS J 12:443–454CrossRefPubMedPubMedCentralGoogle Scholar
  32. Sabeti J, Gerhardt GA, Zahniser NR (2003) Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens. J Pharmacol Exp Ther 305:180–190CrossRefPubMedGoogle Scholar
  33. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS (1997) Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 2:148–155CrossRefPubMedGoogle Scholar
  34. Su T, Suzui M, Wang L, Lin CS, Xing WQ, Weinstein IB (2003) Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci U S A 100:7824–7829CrossRefPubMedPubMedCentralGoogle Scholar
  35. Su HL, Zhu J, Chen YJ, Zhao N, Han W, Dang YH, Xu M, Chen T (2013) Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior. Physiol Behav 118:195–200CrossRefPubMedGoogle Scholar
  36. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227–462CrossRefPubMedGoogle Scholar
  37. Vicente-Sanchez A, Sanchez-Blazquez P, Rodriguez-Munoz M, Garzon J (2013) HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity. Mol Brain 6:42CrossRefPubMedPubMedCentralGoogle Scholar
  38. Volkow ND, Morales M (2015) The brain on drugs: from reward to addiction. Cell 162:712–725CrossRefPubMedGoogle Scholar
  39. Volz TJ, Hanson GR, Fleckenstein AE (2007) The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits. J Neurochem 101:883–888CrossRefPubMedGoogle Scholar
  40. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679–720CrossRefPubMedGoogle Scholar
  41. Zhao N, Chen Y, Zhu J, Wang L, Cao G, Dang Y, Yan C, Wang J, Chen T (2014) Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice. Neuroscience 258:101–110CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Ju-ping Li
    • 1
    • 2
  • Peng Liu
    • 1
  • Gang Lei
    • 1
  • Zheng Chu
    • 1
  • Fei Liu
    • 1
    • 3
  • Chao-feng Shi
    • 4
  • Yong-hui Dang
    • 1
    • 5
    • 6
    Email author
  • Teng Chen
    • 1
    • 5
    • 6
    Email author
  1. 1.College of Medicine and ForensicsXi’an Jiaotong University Health Science CenterXi’anPeople’s Republic of China
  2. 2.Institute of lawNorthwest University of Political Science and LawXi’anPeople’s Republic of China
  3. 3.Affiliated Stomatology Hospital of Xi’an Jiaotong University Health Science CenterXi’anPeople’s Republic of China
  4. 4.Institute of Material Evidence IdentificationKaifeng Municipal Public Security BureauKaifengPeople’s Republic of China
  5. 5.Key Laboratory of the Health Ministry for Forensic MedicineXi’an Jiaotong UniversityXi’anPeople’s Republic of China
  6. 6.Key Laboratory of Forensic Medicine of Shaanxi ProvinceXi’an Jiaotong University Health Science CenterXi’anPeople’s Republic of China

Personalised recommendations